These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11400000)

  • 21. Acute tubulointerstitial nephritis attributable to indinavir therapy.
    Jaradat M; Phillips C; Yum MN; Cushing H; Moe S
    Am J Kidney Dis; 2000 Apr; 35(4):E16. PubMed ID: 10739809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indinavir nephrolithiasis in warm climates.
    Bach MC; Godofsky EW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):296-7. PubMed ID: 9117466
    [No Abstract]   [Full Text] [Related]  

  • 23. Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis.
    Witte M; Tobon A; Gruenenfelder J; Goldfarb R; Coburn M
    J Urol; 1998 Feb; 159(2):498-9. PubMed ID: 9649271
    [No Abstract]   [Full Text] [Related]  

  • 24. Indinavir-associated asymptomatic nephrolithiasis and renal cortex atrophy in two HIV-1 infected children.
    van Rossum AM; Dieleman JP; Fraaij PL; Cransberg K; Hartwig NG; Gyssens IC; de Groot R
    AIDS; 2001 Sep; 15(13):1745-7. PubMed ID: 11546957
    [No Abstract]   [Full Text] [Related]  

  • 25. Indinavir, zidovudine, lamivudine: 3-year follow-up.
    Dworkin MS; Wan PT
    Ann Intern Med; 2001 Jan; 134(2):165. PubMed ID: 11177322
    [No Abstract]   [Full Text] [Related]  

  • 26. Protease inhibitor-induced urolithiasis.
    Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
    Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural history of leukocyturia associated with indinavir treatment in HIV+ individuals.
    Gagnon RF; Tecimer SN; Watters AK; Hatzakis GE; Tsoukas CM
    Am J Nephrol; 2000; 20(6):448-54. PubMed ID: 11146311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urinary lithiasis secondary to indinavir in an HIV-positive patient].
    Moyano Calvo JL; Huesa Martínez I; Cruz Navarro N; Leal Arenas J; León Dueñas E; Morales López A; Maestro Durán JL; Ramírez Mendoza A
    Arch Esp Urol; 2001 Dec; 54(10):1117-20. PubMed ID: 11852520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis.
    Saltel E; Angel JB; Futter NG; Walsh WG; O'Rourke K; Mahoney JE
    J Urol; 2000 Dec; 164(6):1895-7. PubMed ID: 11061951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Light microscopy of indinavir urinary crystals.
    Gagnon RF; Tsoukas CM; Watters AK
    Ann Intern Med; 1998 Feb; 128(4):321. PubMed ID: 9471941
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nephritic colic due to indinavir].
    Hermieu JF; Prévot MH; Ravery V; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
    Presse Med; 1998 Mar; 27(10):465-7. PubMed ID: 9767973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indinavir and renal lithiasis].
    Traba Villameytide ML; Fernández-Guerrero M
    Actas Urol Esp; 2004; 28(7):523-6. PubMed ID: 15384277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of body temperature on indinavir crystallization under loop of Henle conditions.
    Salahuddin S; Kok DJ; Buchholz NN
    J Antimicrob Chemother; 2007 Jan; 59(1):114-7. PubMed ID: 17095526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of escin on indinavir crystallization time in the urine of patients with HIV-I infection: a multicenter, randomized, open-label, controlled, four-period crossover trial.
    Grases F; García-González R; Redondo E; Costa-Bauzá A; Simonet BM; Sartini RP; Bassa A; Gallegos C; Payeras A; Saro D; Martinez AI; Cifuentes C; Homar F; Murillo JA; Fernández C; Riera M; Conte A
    Clin Ther; 2004 Dec; 26(12):2045-55. PubMed ID: 15823768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sudden anuria due to indinavir crystalluria.
    Anglicheau D; Duvic C; Nédélec G
    Nephron; 2000 Nov; 86(3):364-5. PubMed ID: 11096305
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal toxicity of protease inhibitors.
    Olyaei AJ; deMattos AM; Bennett WM
    Curr Opin Nephrol Hypertens; 2000 Sep; 9(5):473-6. PubMed ID: 10990364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of indinavir-associated renal complications in Thai HIV-infected patients.
    Avihingsanon A; Avihingsanon Y; Darnpornprasert P; Kerr S; Ungsedhapand C; Duncombe C; Ubolyam S; Ruxrungtham K; Phanuphak P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S21-7. PubMed ID: 17044450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyuria in patients treated with indinavir is associated with renal dysfunction.
    Sarcletti M; Petter A; Romani N; Lhotta K; König P; Maier H; Zangerle R
    Clin Nephrol; 2000 Oct; 54(4):261-70. PubMed ID: 11076101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anuria in HIV+ patients treated with indinavir].
    Rebassa Llull MJ; Conte Visús A; Grases Freixedas F; Muñoz Vélez D; Mus Malleu A; Torrens Darder I; Sanz-Gadea CG; Ozonas Moragues M
    Arch Esp Urol; 2000 Oct; 53(8):719-21. PubMed ID: 11126974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus.
    Kohan AD; Armenakas NA; Fracchia JA
    J Urol; 1999 Jun; 161(6):1765-8. PubMed ID: 10332431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.